X-53251127-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_001111125.3(IQSEC2):​c.1449G>A​(p.Pro483Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000455 in 1,209,839 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000045 ( 0 hom. 13 hem. )

Consequence

IQSEC2
NM_001111125.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.501

Publications

2 publications found
Variant links:
Genes affected
IQSEC2 (HGNC:29059): (IQ motif and Sec7 domain ArfGEF 2) This gene encodes a guanine nucleotide exchange factor for the ARF family of small GTP-binding proteins. The encoded protein is a component of the postsynaptic density at excitatory synapses, and may play a critical role in cytoskeletal and synaptic organization through the activation of selected ARF substrates including ARF1 and ARF6. Mutations in this gene have been implicated in nonsyndromic X-linked cognitive disability. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
IQSEC2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • intellectual disability, X-linked 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant X-53251127-C-T is Benign according to our data. Variant chrX-53251127-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 390121.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.501 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQSEC2NM_001111125.3 linkc.1449G>A p.Pro483Pro synonymous_variant Exon 5 of 15 ENST00000642864.1 NP_001104595.1 Q5JU85-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQSEC2ENST00000642864.1 linkc.1449G>A p.Pro483Pro synonymous_variant Exon 5 of 15 NM_001111125.3 ENSP00000495726.1 Q5JU85-2

Frequencies

GnomAD3 genomes
AF:
0.0000537
AC:
6
AN:
111684
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000754
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000383
AC:
7
AN:
182568
AF XY:
0.0000296
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000735
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000446
AC:
49
AN:
1098103
Hom.:
0
Cov.:
33
AF XY:
0.0000358
AC XY:
13
AN XY:
363473
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26402
American (AMR)
AF:
0.0000284
AC:
1
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19383
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54143
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40440
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000534
AC:
45
AN:
842094
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46093
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000537
AC:
6
AN:
111736
Hom.:
0
Cov.:
23
AF XY:
0.0000589
AC XY:
2
AN XY:
33944
show subpopulations
African (AFR)
AF:
0.0000651
AC:
2
AN:
30733
American (AMR)
AF:
0.00
AC:
0
AN:
10606
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3551
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2629
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6092
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000754
AC:
4
AN:
53052
Other (OTH)
AF:
0.00
AC:
0
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 18, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Intellectual disability, X-linked 1 Benign:1
Oct 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 23, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
2.7
DANN
Benign
0.58
PhyloP100
0.50
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200629644; hg19: chrX-53280309; COSMIC: COSV64726285; COSMIC: COSV64726285; API